Glenza 40 mg Capsule
  1. Home
  2. Pharma Products
  3. Glenmark Pharmaceuticals Ltd
  4. Glenza 40 mg Capsule

Glenza 40 mg Capsule

Glenza 40 mg Capsule contains enzalutamide 40 mg and is an oral anticancer medicine used in the treatment of prostate cancer. It is taken by mouth with or without food according to the treatment plan prescribed by an oncologist. Enzalutamide blocks androgen receptor signaling, which helps reduce the growth and spread of prostate cancer cells.

BUY NOW

Category

Glenza is an androgen receptor inhibitor used in appropriate treatment regimens for advanced prostate cancer, including certain metastatic and castration-resistant conditions. Enzalutamide works by inhibiting several steps in androgen receptor signaling that contribute to prostate cancer cell growth and survival. The dose and duration of treatment are determined by the treating physician according to the patient’s disease status and overall therapy. Patients may require monitoring for adverse effects such as fatigue, hypertension, falls, fractures, and neurological reactions.

Technical Specification

Specification Details
Active Ingredient Enzalutamide
Strength 40 mg
Dosage Form Capsule
Route of Administration Oral
Therapeutic Class Antineoplastic
Drug Class Androgen Receptor Inhibitor

Product Also Known As

Glenza 40mg Capsule, Glenza 40 mg Soft Capsule, Enzalutamide 40mg Capsule, Enzalutamide 40 mg Capsule, Enzalutamide 40mg Softgel Capsule, Enzalutamide Prostate Cancer Capsule